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Abstract
Background: Cerebrospinal fluid (CSF)/serum quotient graphs have been used previously to
determine local synthesis in brain of immunoglobulins and C3 complement component. The aim of
this study was to use the same technique to construct quotient graphs, or Reibergrams, for the
beta globulin C4 and to evaluate the method for assessing intrathecal synthesis in neurological
disease.
Methods: The constants in the previously-defined Reibergram for immunoglobulin IgA were used
to calculate the CSF/serum quotient for C4. CSF and serum were analyzed for C4, IgA and albumin
from a total of 12 patients with meningoencephalitis caused by encapsulated microorganisms and
10 subjects without infections or inflammatory neurological disease, some of which had dysfunction
of the blood-CSF barrier,
Results: The formula and C4 Reibergram with the constants previously found for IgA, determined
the intrathecal C4 synthesis in CSF. The intrathecal C4 fraction in CSF (C4 loc in mg/l) was compared
to the C4-Index (fraction of CSF: serum for C 4/fraction of CSF: serum for albumin). There was a
significant correlation between the two formulae. The CSF/Serum quotient graph was superior for
detecting intrathecal synthesis of C4 under variable conditions of blood-CSF barrier permeability.
Conclusion:  The C4 Reibergram can be used to quantify the intrathecal synthesis of this
component of the complement system in different infectious diseases of the central nervous system
and is especially useful for patients with blood-brain barrier dysfunction.
Background
Cerebrospinal fluid (CSF) analysis has great potential for
the diagnosis of neurological diseases. Reibergrams or
CSF/serum quotient graphs [1,2] are diagrams that ana-
lyze in an integrated way both the function of the blood-
CSF barrier and intrathecal protein synthesis, to aid in the
diagnosis of central nervous system (CNS) diseases asso-
ciated with specific patterns of immunoglobulin
response. This diagram was first defined for the major
classes of immunoglobulins [2,3] empirically based on
the results of thousands of profiles and was subsequently
confirmed by application of Fick's law of diffusion in the
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theory of molecular diffusion/flow rate [4]. Fick's law
states that the diffusion of a protein through a barrier
depends on the diffusion coefficient of the molecule and
on the concentration gradient between the compartments
on either side of the barrier. The diffusion coefficient
depends on the molecular size of the protein. Fick's sec-
ond law shows how the local concentration gradient is
nonlinearly modified by variations in the CSF flow rate.
The theory of molecular diffusion/flow rate of CSF
explains that the diffusion of proteins through the blood/
CSF barrier has a hyperbolic distribution and is able to
explain the physiological and pathophysiological dynam-
ics of proteins in the CNS. This has permitted its use for
other immunoglobulins such as IgG3 [5], IgE [6] and more
recently C3c [7].
The complement system is one of the humoral mediators
of immunity and inflammation; it is formed by more than
thirty plasma and membrane proteins. Raised levels of C4,
one of the components, may be found in the CSF in lupus
meningoencephalitis [8,9], in progressive supranuclear
palsy [10] and other neurological diseases [11] such as
autism [12], schizophrenia [13], cerebral parenchymal
cysticercosis [14], meningoencephalitis [15] and brain
tumors [16]. Cytokines associated with amyloid plaques
in Alzheimer's disease stimulate human glial and neuro-
nal cell cultures to secrete early complement proteins
[17,18]. Some of these proteins are bound to immu-
noglobulins or to components of the cellular membrane
[19], although they normally circulate in the form of pro-
enzymes with a latent pro-enzyme activity.
C4 protein is a beta globulin with a sedimentation coeffi-
cient of 18.7, molecular weight 200 kDa and a serum con-
centration of 430 μg/mL. It is activated by the
complement system and is a C2 receptor. C4a acts as ana-
phylatoxin similar to C3abut is weaker, while C4b acts as an
opsonin promoting phagocytosis by binding to comple-
ment receptors. It is important to assess C4 intrathecal syn-
thesis if the classical complement pathway has been
activated in infectious and autoimmune neurological dis-
eases. Combined with analysis of C3c intrathecal synthesis
[20,21], this knowledge is needed to understand the
pathophysiology of these disorders.
The aim of this paper was to construct quotient graphs
(Reibergrams) for the beta globulin C4 and to determine
the intrathecal synthesis of C4 in patients with bacterial
meningoencephalitis. To do this we used IgA which has
molecular characteristic similar to the C4 molecule and its
previously-defined CSF/serum quotient graph, to create
the formula and Reibergram for C4.
Methods
Patients
Twelve patients with meningoencephalitis caused by
encapsulated microorganisms were studied: nine patients
suffering from Streptococcus pneumoniae and three with
Haemophilus influenzae (mean age of 32.5 years, range 3 to
46 years). A control group consisted of ten subjects with-
out infections or inflammatory neurological disease and
that did or did not have dysfunction of the blood-CSF bar-
rier (mean age 17 years, range 9 months to 48 years), The
research was approved by the Committee on Bioethics
Research of the Faculty of Medical Sciences, Dr. Miguel
Enriquez Superior Institute of Medical Sciences of
Havana, Havana City, Cuba. All patients and persons
whose samples were used as controls, and parents or
tutors of the children gave their informed consent to carry
out a diagnostic lumbar puncture.
CSF and serum samples
CSF samples were obtained by lumbar puncture and
simultaneous blood samples were taken to obtain serum.
Cells were removed from CSF by centrifugation and sam-
ples with blood contamination were eliminated. Control
samples were from CSF and serum collections held in our
laboratory from patients with suspicion of meningoen-
cephalitis but were subsequently found to have febrile
convulsions without biological agents or verified autoim-
mune causes. Aliquots of both patient and control sam-
ples were kept at -70°C for up to 30 days after the
puncture date before analysis.
Analysis of CSF and serum
C4, IgA and albumin were quantified by radial immunod-
iffusion with NOR PARTIGEN© and LC PARTIGEN© plates
(Dade Behring, Marburg, Germany) for serum and CSF,
respectively. Radial immunodiffusion detects the reaction
of antigen and antibody by a precipitation reaction based
on the principle that a quantitative relationship exists
between the amount of antigen placed in a well cut in the
agar-antibody plate and the resulting ring of precipitation.
This end point method requires that the precipitation
rings reach the maximal possible size, which often
requires 48–72 h of diffusion. A standard curve was exper-
imentally determined with known standards and used for
the determination of protein concentration correspond-
ing to any diameter size.
C4 Reibergram and index
The CSF/Serum quotient graph or Reibergram for C4 was
created taking into consideration the molecular character-
istics of this protein. In addition, the C4-Index was calcu-
lated using the following formula [22]:
C Index C  CSF C  serum Albumin CSF Albumin serum Q C 44 4 −= = (/ ) / ( / ) 4 4 /QAlbCerebrospinal Fluid Research 2009, 6:8 http://www.cerebrospinalfluidresearch.com/content/6/1/8
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As a cut off for discrimination between a normal and
pathological C4-Index, we used C4-Index = 0.46
Among proteins found in CSF and serum, C4 is most sim-
ilar to IgA in terms of molecular characteristics (Table 1).
The constants used for the creation of the formula for
intrathecal C4 detection were those for IgA [3] which are
likely to be similar to C4 according to Fick's law of diffu-
sion. Hence the Reiber's quotient for C4 was calculated
using the following formula:
Where Q C4 (lim) is the upper discrimination line of the
reference range, Q C4 = C4 (CSF)/C4 (Serum), a = intercept
hyperbole value on the y axis, b = x value to asymptotic
hyperbole line, c = constant and a/b = hyperbole slope.
The following values previously obtained for IgA were
used: a/b = 0.77, b2 = 23 × 10-6, c = 3.1 × 10-3.
Thus the formula for the amount of locally-synthesized C4
in the CSF or C4 (loc) is:
The program MEDCALC version 6.0 was used to perform
the statistical comparison.
Results
The Q C4 quotient graph for the patients and controls
under study with a range of values of Q albumin (QAlb)
is shown in figure 1. The Q C4 values for all twelve patients
with meningoencephalitis are above the lower thin hyper-
bolic line. For nine of these twelve patients Q C4 was
located above the upper solid line showing that these
patients synthesized C4 intrathecally. The Q C4 for all con-
trol patients is in the area between the thick hyperbolic
line and the lower thin line, indicating that there is no
CNS synthesis of this component. Also included is the
QIgA of the patients with inflammatory meningoen-
cephalitis and only five of these are in the region that indi-
cates intrathecal synthesis. Another two patients had no
detectable IgA in CSF. Hence the pattern of intrathecal
synthesis of IgA is not the same as for C4, suggesting that
IgA has a different role in the immune response, despite
the similar molecular flux from blood to CSF according to
the molecular size. Mean values, range and coefficient of
variation for C4 and IgA in serum and CSF are shown in
Table 2.
Hitherto, the formula used to quantify the intrathecal syn-
thesis of C4 complement has been the C4-Index [22,23]. In
this study, the results obtained from the CSF/Serum quo-
tient formula were compared to C4-Index values. Using
C4-Index, among the non-inflammatory controls, there
were 2 false positives, although intrathecal complement
synthesis should not occur in such cases. With C4-Index >
0.46 we find in 10/12 case of meningoencephalitis a path-
ological increase, i.e. an intrathecal synthesis (Table 3).
There was a positive correlation between the C4-Index and
the CSF/Serum quotient graph for C4, r = 0.7287 and
range 0.4432 – 0.8800, for a confidence interval of 95%,
p = 0.0001. The general sensitivity of C4-Index, i.e. the
probability that this result will be positive when the
inflammatory process is present, was only 66% of true
positive rate. The C4-Index general specificity was 85%,
meaning that the probability that the C4-Index will be
negative when the inflammatory process is not present
was 85% of true negative. The positive predictive value or
the probability that the inflammatory process is present
when the index is positive was 75% and the negative pre-
dictive value or the probability that the inflammatory
process is not present when the index is negative was 80%.
Hence the C4 quotient method (Reibergram) was found to
be superior in sensitivity, specificity and predictive values.
Discussion
The complement system consists of more than thirty pro-
teins and has three types of activation pathways: classical,
lectin and alternative pathways. The complement system
not only has a role in innate immunity but also works as
an antibody-dependent effector to eliminate pathogens.
In serum, normal or decreased levels of C3 and C4 are asso-
ciated with specific immune-mediated diseases. In
patients with immune-mediated diseases in the CNS, it is
essential to measure complement activation in CSF and
the intrathecal synthesis of complement proteins.
The immune response within the CNS has specific charac-
teristics associated with a reduced immunological envi-
ronment, being a unique and special compartment
without much peripheral regulation. The CNS humoral
immune response is different from the immune response
observed in blood, mainly because there is no switch from
the IgM class response to IgG or IgA class response in the
CSF in the course of inflammatory neurological disease.
The pattern of intrathecal IgG/IgA/IgM synthesis remains
fairly constant and depends on the cause, pathophysiol-
ogy and localization of the disease process [3,4]. In addi-
QC
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Table 1: Molecular characteristics of immunoglobulins and 
complement proteins
IgG1 IgA IgM C3c C4
Molecular Mass (kDa) 150 160 900 145 200
Hydrodynamic radius (nm) 52 58 270 54 65Cerebrospinal Fluid Research 2009, 6:8 http://www.cerebrospinalfluidresearch.com/content/6/1/8
Page 4 of 6
(page number not for citation purposes)
Table 2: Mean value, range and coefficient of variation (CV) in 
CSF and serum for C4and IgA
Meningoencephalitis Controls
Size (n) 12 10
CSF C4 (mg/L) Mean 12.07 2.43
Range 0.17–114 0.17–12
CV 2.67 1.60
Serum C4 (g/L) Mean 1.12 1.08
Range 0.19–5.6 0.37–5.6
CV 0.71 1.56
Q C4 × 103 Mean 7.35 1.49
Range 1.1–39.4 0.38–10.8
CV 1.45 1.79
Q Alb × 103 Mean 5.91 5.36
Range 0.3–17.1 0.3–27.41
CV 0.79 0.99
C4-Index Mean 1.91 0.74
Range 0.3–5.05 0.02–3.66
CV 0.96 1.49
CSF IgA (mg/L) Mean 1.09 1.28
Range 0.17–4.62 0.32–5.6
CV 1.17 1.37
Serum IgA (g/L) Mean 1.12 0.67
Range 0.32–5.6 0.17–1.7
CV 1.38 0.90
QIgA × 103 Mean 1.76 0.92
Range 0.16–10.62 0.16–3.5
CV 1.05 1.34
Notes:
Q = quotient (CSF/Serum)
Alb = Albumin
C4-Index = (C4 CSF/C4 serum)/(Albumin CSF/Albumin serum)
CSF/serum quotient diagram for C4 (Reibergram) Figure 1
CSF/serum quotient diagram for C4 (Reibergram). 
The upper hyperbolic curve (thick line) represents the dis-
crimination line between brain-derived and blood-derived 
protein. Values above this upper line represent intrathecal C4 
synthesis. The dashed hyperbolic lines indicate the extent of 
intrathecal synthesis as intrathecal fractions with 20, 40, 60, 
and 80% of the measured total immunoglobulin concentra-
tion in CSF, with reference to the discrimination line as 0% 
intrathecal synthesis. The limit of the reference range for 
QAlbumin between normal and increased CSF protein con-
centrations due to blood-CSF barrier dysfunction is indicated 
by the age-dependent vertical lines at Q Albumin 5.5 × 10-3 
(up to 15 years), at QAlbumin 6.5 × 10-3 (up to 40 years), 
and at Q Albumin 8 × 10-3 (up to 60 years). Nine of the 
patients with neurological infectious meningoencephalitis 
(Black circle) had values above the upper solid line which 
indicate intrathecal synthesis of C4. Ten controls (Black trian-
gle) without infectious neurological disorders had values in 
the normal range, indicating no intrathecal C4 synthesis. Also 
plotted are QIgA (White triangle) from 10 patients suffering 
from meningoencephalitis and five of these had IgA intrathe-
cal synthesis. Two patients had no detectable IgA in CSF.Cerebrospinal Fluid Research 2009, 6:8 http://www.cerebrospinalfluidresearch.com/content/6/1/8
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tion, it is known that there is a long-lasting but slow decay
of intrathecal antibody synthesis, sometimes detectable
up to 20 years after sufficient treatment (e.g. in neu-
rosyphilis, neuroborreliosis or HSV-encephalitis). In CSF,
there are polyclonal and polyspecific immune responses
in diseases like multiple sclerosis [20,24]. Recent studies
have demonstrated that the intrathecal synthesis of C3c is
associated with infectious [14] and autoimmune disease
[15].
Studies carried out on the passage of different blood pro-
teins into the CSF have established different models that
tried to explain their differential diffusion into the cere-
bral compartment. The theory of protein flux/CSF flow
[4,24] suggests that there is no loss of selectivity during
dysfunction of the blood-CSF barrier, and that the only
variable determining the speed of passage of a blood pro-
tein into CSF is the coefficient of molecular diffusion
which is inversely proportional to the molecular size of
the protein. The protein concentrations in CSF depend on
blood concentration, blood-CSF barrier function and
intrathecal synthesis [25]. In order to know if a protein in
CSF is brain-derived it should have at least one of the fol-
lowing characteristics: a higher CSF concentration than in
serum, the blood-derived fraction in CSF significantly
lower than brain-derived fraction, or if the coefficient of
variation (CV) of the serum concentrations is larger than
CV in CSF. In our experiment, the C4 concentration in
blood was larger than in CSF in controls and in patients
with meningoencephalitis. In the patient group, the CV in
CSF was larger than in serum but in the control group, the
CV was not larger in CSF than in blood. This suggests that
although C4 is a blood-derived protein, during the inflam-
mation process there was an increased amount produced
in brain. This study showed that 75% of patients with
meningoencephalitis had intrathecal C4 synthesis with or
without dysfunction of the blood-CSF barrier as indicated
by its QAlb value which varies according to age. In addi-
tion, the control group with variable QAlb values was in
the normal range, indicating no intrathecal synthesis,
which is consistent with the absence of cerebral inflam-
mation in this group [26]. Also noteworthy is that none of
the evaluated cases was placed below the lower hyperbolic
curve, which is an area with no biological explanation. In
medical practice, a technical error in protein quantifica-
tion is suspected when a case falls in this area, so this is a
quality control for the method.
Using the previously-used C4-Index to study intrathecal
C4synthesis has disadvantages over the quotient method.
The index is a linear formula whereas the distribution of
proteins from blood to cerebral compartments follows a
hyperbolic curve [1], thus the C4-Index may produce false
results [25]. In addition, indexes can not be applied when
there is a dysfunction of the blood-CSF barrier, which
greatly limits its application in inflammatory diseases that
usually involve barrier dysfunction. There is also a practi-
cal problem; the values of the index vary with the volume
of extracted CSF since there is a rostro-caudal concentra-
tion gradient of proteins passing into CSF, and the first
and the following volumes collected have different con-
centrations [27]. However, it has been demonstrated that
since the Reibergram works with protein quotients nor-
malized to quotient (CSF/serum) these are not affected by
the extracted CSF volume [1,25,27].
Despite these limitations, the results of the C4 Reibergram
were compared to those of the index since there is no
other known gold standard. There was a positive signifi-
cant statistical correlation between both methods. Never-
theless, these results demonstrated the superior diagnostic
value of Reibergram.
Conclusion
Under all conditions of the blood-CSF barrier, the CSF/
Serum quotient graph can identify the occurrence of
intrathecal C4 synthesis. It can quantify the C4 fraction
which is locally produced in the CNS and differentiate
from C4 that may have entered the CSF from blood. On
the other hand, the C4-Index should not be used in
patients with low QAlb and in particular with high QAlb,
i.e. with blood-CSF barrier dysfunction.
Table 3: Comparison of the results for intrathecal fraction of C4 in CSF calculated as C4 loc (mg/l) and as the C4-Index in patients with 
inflammatory disease and non-inflammatory controls.
Intrathecal C4 fraction C4-Index
C4 loc > 0 C4 loc < 0 > 0.46 < 0.46
Meningoencephalitis 9/12 3/12 10/12 2/12
Non inflammatory controls 0/10 10/10 2/10* 8/10
The discrimination cut off for the C4-Index = 0.46.
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